Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lyn S Pilowsky

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Biological Psychiatry|July 5, 2005
Impact of schizophrenia and chronic antipsychotic treatment on [123I]CNS-1261 binding to N-methyl-D-aspartate receptors in vivoRodrigo A Bressan, Kjell Erlandsson, James M Stone, et al.
Nuclear Medicine and Biology|March 21, 2006
Ketamine displaces the novel NMDA receptor SPET probe [(123)I]CNS-1261 in humans in vivoJames M Stone, Kjell Erlandsson, Erik Arstad, et al.
Annals of the New York Academy of Sciences|December 20, 2003
Evaluation of NMDA receptors in vivo in schizophrenic patients with [123I]CNS 1261 and SPET: preliminary findingsRodrigo A Bressan, Kjell Erlandsson, Rachel S Mulligan, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 2, 2004
Clinical effectiveness in first-episode patientsRuth I Ohlsen, Mary S O'Toole, Rick G Purvis, et al.
Psychopharmacology|January 8, 2008
Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy: a [(123)I]CNS-1261 SPET studyJames M Stone, Kjell Erlandsson, Erik Arstad, et al.
Biological Psychiatry|December 17, 2004
Cortical effects of quetiapine in first-episode schizophrenia: a preliminary functional magnetic resonance imaging studyHugh M Jones, Michael J Brammer, Mary O'Toole, et al.
Bioorganic & Medicinal Chemistry|April 20, 2006
Closing in on the AMPA receptor: synthesis and evaluation of 2-acetyl-1-(4'-chlorophenyl)-6-methoxy-7-[11C]methoxy-1,2,3,4-tetrahydroisoquinoline as a potential PET tracerErik Arstad, Rosaria Gitto, Alba Chimirri, et al.
Nuclear Medicine and Biology|May 28, 2003
Kinetic modelling of [123I]CNS 1261--a potential SPET tracer for the NMDA receptorKjell Erlandsson, Rodrigo A Bressan, Rachel S Mulligan, et al.
Nuclear Medicine and Biology|March 12, 2004
A bolus/infusion paradigm for the novel NMDA receptor SPET tracer [123I]CNS 1261Rodrigo A Bressan, Kjell Erlandsson, Rachel S Mulligan, et al.
Journal of Psychopharmacology (Oxford, England)|September 21, 2010
Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET studyEmma Barkus, Paul D Morrison, D Vuletic, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Biological Psychiatry|July 5, 2005
Impact of schizophrenia and chronic antipsychotic treatment on [123I]CNS-1261 binding to N-methyl-D-aspartate receptors in vivoRodrigo A Bressan, Kjell Erlandsson, James M Stone, et al.
Nuclear Medicine and Biology|March 21, 2006
Ketamine displaces the novel NMDA receptor SPET probe [(123)I]CNS-1261 in humans in vivoJames M Stone, Kjell Erlandsson, Erik Arstad, et al.
Annals of the New York Academy of Sciences|December 20, 2003
Evaluation of NMDA receptors in vivo in schizophrenic patients with [123I]CNS 1261 and SPET: preliminary findingsRodrigo A Bressan, Kjell Erlandsson, Rachel S Mulligan, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 2, 2004
Clinical effectiveness in first-episode patientsRuth I Ohlsen, Mary S O'Toole, Rick G Purvis, et al.
Psychopharmacology|January 8, 2008
Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy: a [(123)I]CNS-1261 SPET studyJames M Stone, Kjell Erlandsson, Erik Arstad, et al.
Biological Psychiatry|December 17, 2004
Cortical effects of quetiapine in first-episode schizophrenia: a preliminary functional magnetic resonance imaging studyHugh M Jones, Michael J Brammer, Mary O'Toole, et al.
Bioorganic & Medicinal Chemistry|April 20, 2006
Closing in on the AMPA receptor: synthesis and evaluation of 2-acetyl-1-(4'-chlorophenyl)-6-methoxy-7-[11C]methoxy-1,2,3,4-tetrahydroisoquinoline as a potential PET tracerErik Arstad, Rosaria Gitto, Alba Chimirri, et al.
Nuclear Medicine and Biology|May 28, 2003
Kinetic modelling of [123I]CNS 1261--a potential SPET tracer for the NMDA receptorKjell Erlandsson, Rodrigo A Bressan, Rachel S Mulligan, et al.
Nuclear Medicine and Biology|March 12, 2004
A bolus/infusion paradigm for the novel NMDA receptor SPET tracer [123I]CNS 1261Rodrigo A Bressan, Kjell Erlandsson, Rachel S Mulligan, et al.
Journal of Psychopharmacology (Oxford, England)|September 21, 2010
Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET studyEmma Barkus, Paul D Morrison, D Vuletic, et al.
Pageof 6